U2FP, Working 2 Walk, Oct 16th at 9:45AM at Hilton Rockville, Washington D.C. Joseph Gold PhD Senior Director at Geron will give a update on Phase 1 Safety Trial of Human Embryonic Stem-Cell GRNOPC1 in subjects with neurologically complete, subacute spinal cord injuries. Geron is up 5% I think people are hoping for good news Sunday. The volume is not there, yet. Will sell some puts if we get to $3 before the Oct 16th update. If there is an increase in volume say 2 million+ shares a day before update I will not sell puts.
Good luck in this rigged casino,
No comments:
Post a Comment